Trials / Completed
CompletedNCT06814483
Effects Multimodal Mind and Body Approach for MCI
Modulation Effects of a Computer-based Multimodal Mind and Body Approach for Mild Cognitive Decline
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this application is to develop a computer-based multimodal mind and body approach (CMMBA) for mild cognitive impairment (MCI). This product will provide a new, cost-effective and easily accessible treatment option for MCI and potentially other age-related dementia.
Detailed description
The goal of this Phase I R41 (STTR) application is to develop a computer-based multimodal mind and body approach (cbMMBA) to improve the cognitive function for mild cognitive impairment (MCI). This application, if successful, will provide a cost-effective and easily accessible treatment option for MCI and other age-related dementia, significantly improve the prevention of MCI development, and directly benefit patients suffering from the highly prevalent disorder, particularly for those who may have limited access to in-person mind and body interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Experimental: A computer-based multimodal mind and body approach (cbMMBA) | cbMMBA will include three modules: BDJ, acupressure, and relaxation techniques including deep breathing, guided imagery, and progressive muscle relaxation. |
| BEHAVIORAL | A standard cognitive training group | The program uses paper puzzles (Sudoku, crosswords, word-search, etc.) to engage subjects |
Timeline
- Start date
- 2023-12-11
- Primary completion
- 2025-04-11
- Completion
- 2025-07-15
- First posted
- 2025-02-07
- Last updated
- 2026-03-09
- Results posted
- 2026-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06814483. Inclusion in this directory is not an endorsement.